Evidence map›Paper›PMID 31536524›Full record

ArticlePloS one2019

NGS analysis in Marfan syndrome spectrum: Combination of rare and common genetic variants to improve genotype-phenotype correlation analysis.

Davide Gentilini, Antonino Oliveri, Teresa Fazia, Alessandro Pini, Susan Marelli, Luisa Bernardinelli, Anna Maria Di Blasio

Abstract read
In one paragraph

Article in PloS one, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed.

  1. Article
  2. Article
  3. A novel missense variant ofFrontiers in pediatrics · 2025
    Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. The Molecular Genetics of Marfan Syndrome.International journal of medical sciences · 2021
    Review
  14. Article
  15. Is HSPG2 a modifier gene for Marfan syndrome?European journal of human genetics : EJHG · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Davide GentiliniDepartment of Brain and Behavioral Sciences, University of Pavia, Pavia, Italy.ORCID 0000-0002-8391-0725
Antonino OliveriDepartment of Brain and Behavioral Sciences, University of Pavia, Pavia, Italy.ORCID 0000-0003-2621-6443
Teresa FaziaDepartment of Brain and Behavioral Sciences, University of Pavia, Pavia, Italy.ORCID 0000-0002-9577-8450
Alessandro PiniRare Disease Center, Marfan Clinic, Cardiology department, ASST-FBF-Sacco, Milano, Italy.
Susan MarelliRare Disease Center, Marfan Clinic, Cardiology department, ASST-FBF-Sacco, Milano, Italy.
Luisa BernardinelliDepartment of Brain and Behavioral Sciences, University of Pavia, Pavia, Italy.ORCID 0000-0002-7551-6664
Anna Maria Di BlasioIstituto Auxologico Italiano IRCCS, Molecular Biology Laboratory, Cusano Milanino, Milano, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The diagnosis of Marfan spectrum includes a large number of clinical criteria. Although the identification of pathogenic variants contributes to the diagnostic process, its value to the prediction of clinical outcomes is still limited. An important novelty of the present study is represented by the statistical approach adopted to investigate genotype-phenotype correlation. The analysis has been improved considering the extended genetic information obtained by Next Generation Sequencing (NGS) and combining the effects of both rare and common genetic variants in an inclusive model. To this aim a cohort of 181 patients were analyzed with a NGS panel including 11 genes associated with Marfan spectrum. The genotype-phenotype correlation was also investigated considering the possibility to predict presence of a pathological mutation in Marfan syndrome (MFS) main genes based only on the analysis of phenotypic traits. Results obtained indicate that information about clinical traits can be summarized in a new variable that resulted significantly associated with the probability to find a pathological mutation in MFS main genes. This is important since the choice of the genetic test is often influenced by the phenotypic characterization of patients. Moreover, both rare and common variants were found to significantly contribute to clinical spectrum and their combination allowed to increase the percentage of phenotype variability that could be explained based on genetic factors. Results highlight the opportunity to take advantage of the overall genetic information obtained by NGS data to have a better clinical classification of patients.

Indexed as

AdultFemaleGenetic Association StudiesGenetic Predisposition to DiseaseGenetic VariationHigh-Throughput Nucleotide SequencingHumansMaleMarfan SyndromeQuality Improvement

Identifiers

PMID31536524
PMCPMC6752800

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.